Saturday, 1st September Melbourne Immunotherapy Network Winter Retreat 2018

• Personalised healthcare for cancer treatment. - Shahneen Sandhu

• Evolution of Cancer Immunotherapy - Ramy Ibrahim
• Modelling resistance to adoptive T-cell immunotherapy in melanoma using CRISPR/Cas9 - Maike Effern
• Impact of tumour inherent interferons on immune reactivity and personalised therapy in TNBC - Natasha K Brockwell
• Targeting the adenosine pathway to enhance CAR T cell therapy against solid tumours - Kevin Sek
• Breast-implant associated anaplastic large cell lymphoma - is this the one of a few non-viral antigenically driven T cell lymphomas? - Miles Prince

• Control of Immunopathology in CNS autoimmunity - Thomas Korn
• Combination immunotherapy; Looking beyond PD-1/PD-L1 blockade - Promises and Failures - Oliver Klein
• Venetoclax and Chronic Lymphocytic Leukaemia - Mary Ann Anderson
• TCF-1 Critically Regulates CD8⁺T cell Fate and IL-17 Production - Lisa Mielke
• Maintenance of CD8 T cell responses during chronic infection and anti-tumor immunity - Axel Kallies
• Targeting phosphatases to promote ant-tumour immunity - Tony Tiganis

• Harnessing the innate immune response to treat small cell lung cancer. - Jonas Hess
• Rational design of cancer vaccines by targeting dendritic cells - Filipp Esselborn
• Chronic inflammation and bowel cancer; are your MAITs involved? - Jason Kelly
• Stat3 inhibition in the tumour microenvironment restricts colorectal tumour growth in mice - Mariah M Alorro
• More than a BTK inhibitor: Ibrutinib impairs T cell function - Chia Sharpe
• The interplay among diverse cell types in prostate tumour microenvironment contributes to the activation of key hallmarks - Stefano Mangiola

• Immunotherapy in monogenic disease. - Ingrid Winship
• Rational design of cancer vaccines    - Irina Caminschi
• Tissue-resident Memory CD8⁺ T Cells Promote Melanoma-immune Equilibrium in Skin - Simone L Park
• Investigating the role of Mucosal-Associated Invariant T (MAIT) cells in cancer - Emma V Petley
• ALK4 signaling suppresses NK cell function to aid tumor immune evasion - Fernando Guimaraes
• Emerging strategies to target NK cells in cancer immunotherapy - Nicholas Huntington

Grant McArthur

Laura Mackay

Ramy Ibrahim

Fabienne Mackay

Jonathan Cebon